Pneumococcal conjugate vaccines — implications for community antibiotic prescribing
- 1 October 2000
- journal article
- review article
- Published by Elsevier in Current Opinion in Microbiology
- Vol. 3 (5) , 502-507
- https://doi.org/10.1016/s1369-5274(00)00130-2
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- ANTIBIOTICS FOR GRAM-POSITIVE BACTERIAL INFECTIONS: Vancomycin, Teicoplanin, Quinupristin/Dalfopristin, and LinezolidInfectious Disease Clinics of North America, 2000
- Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in childrenThe Pediatric Infectious Disease Journal, 1999
- The epidemiology of pneumococcal infection in children in the developing worldPhilosophical Transactions Of The Royal Society B-Biological Sciences, 1999
- Acute otitis media: management and surveillance in an era of pneumococcal resistance-a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working GroupThe Pediatric Infectious Disease Journal, 1999
- The burden of pneumococcal disease: the role of conjugate vaccinesVaccine, 1999
- Prevalence of Antimicrobial Resistance Among Respiratory Tract Isolates ofStreptococcus pneumoniaein North America: 1997 Results from the SENTRY Antimicrobial Surveillance ProgramClinical Infectious Diseases, 1998
- Three-Year Multicenter Surveillance of Systemic Pneumococcal Infections in ChildrenPediatrics, 1998
- Drug‐ResistantStreptococcus pneumoniaeClinical Infectious Diseases, 1998
- The Challenge of Penicillin-Resistant Streptococcus pneumoniae Meningitis: Current Antibiotic Therapy in the 1990sClinical Infectious Diseases, 1997
- Therapy for Children With Invasive Pneumococcal InfectionsPediatrics, 1997